. b) ESI-MS of anti-Her2 S202pAcPhe Fab. Expected mass: 47860. ESI-MS: 47861 (Hutchins et al., 2010) . c) SDS-page gel of Saporin 6 A157C with and without 100 mM dithiothreitol (DTT). Gel is stained with Gel Code (Thermo Scientific). d) ESI Effect of anti-Her2 pAcPhe Fab-Saporin 6 A157C conjugates on the viability of additional human breast cancer cells. SKBR3 cells naturally overexpress Her2. BCM2 cells are Her2 negative. A Her2 positive variant was generated using lentiviral transduction as described for MDA-MB-435.
Supplemental Experimental Procedures Her2 Transfection with Lentivirus
Human breast cancer cells were cultured in Eagle's minimum essential medium supplemented with non-essential amino acids, vitamin mix, L-glutamine, pyruvate, and 10% FBS. For Her2 expression, MDA-MB-435 and BCM2 cells were transduced with a self inactivating lentiviral vector system (Tschan et al., 2003) engineered to contain full length human Her2. Her2 overexpressing cell populations were isolated by fluorescence activated cell sorting. Her2 expression was analyzed with anti-Her2 Fab by flow cytometry. The engineered Her2 overexpressing cell variants of MDAMB 435 and BCM2 express the receptor at levels comparable to that found in SKBR3 cells, which naturally overexpress Her2.
Synthesis of Orthogonal Linker
The desired O-protected oxyamine 2 was obtained by heating commercial 3-bromohexanol with N-hydroxyphthalimide at 50°C in DMF in the presence of potassium carbonate. The aminoxy group was then deprotected using hydrazine in EtOH to afford linker 3 (Defrancq et al., 2001 ). The dimethoxytrityl (DMT) protecting group was introduced to yield compound 4, which, under Mitsunobu conditions, led to the protected aminooxy-maleimide linker 5 (Toyokuni et al., 2003) . The DMT group was easily removed with HCl, producing the desired compound 5 as an HCl salt (Berndt et al., 2007) . NMR and mass spectrometry was consistent with previously reported values. ESI-TOF high-accuracy: 213.1 [M+H] .
